{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:58:36Z","timestamp":1761674316653,"version":"3.41.2"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The main symptoms of Kawasaki disease (KD) are inflammatory vasculitis characterized by fever lasting 1\u20132 weeks, failure to respond to antibiotic treatment, conjunctivitis, redness of the lips and mouth, strawberry tongue, and painless enlargement of the neck lymph nodes. Studies have been shown that tumor necrosis factor (TNF) and TNF receptor family members are abnormally expressed in the acute phase of Kawasaki disease, also revealing that these two play a significant role in the pathogenesis of KD. The purpose of our study is to determine the relationship between <jats:italic>TNFRSF11A rs7239667<\/jats:italic> and the pathogenesis of KD and Coronary artery lesions in KD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and Results<\/jats:title><jats:p>In this study, <jats:italic>TNFRSF11A<\/jats:italic> (<jats:italic>rs7239667<\/jats:italic>) genotyping was performed in 1396 patients with KD and 1673 healthy controls. Our results showed that <jats:italic>G<\/jats:italic> &amp;gt; <jats:italic>C<\/jats:italic> polymorphism of <jats:italic>TNFRSF11A<\/jats:italic> (<jats:italic>rs7239667<\/jats:italic>) was not associated with KD susceptibility. In addition, the patients with KD were divided into CAA and NCAA groups according to whether they had coronary artery aneurysm (CAA) or not, and the <jats:italic>TNFRSF11A rs7239667<\/jats:italic> genotyping was performed in the two groups. After gender and age calibration, We found that genotype CC of <jats:italic>TNFRSF11A<\/jats:italic> may be a protective factor in KD coronary artery damage (adjusted OR = 0.69 95% CI = 0.49\u20130.99 <jats:italic>P<\/jats:italic> = 0.0429) and is more significant in children with KD \u2264 60 months (adjusted OR = 0.49 95% CI = 0.49\u20130.93 <jats:italic>P<\/jats:italic> = 0.0173).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study suggests that <jats:italic>TNFRSF11A rs7239667 G<\/jats:italic> &amp;gt; <jats:italic>C<\/jats:italic> polymorphism maybe play a protective gene role for the severity of KD coronary artery injury and is related to age, which has not been previously revealed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2021.691282","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T10:22:02Z","timestamp":1629195722000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Protective Effect of TNFRSF11A rs7239667 G &gt; C Gene Polymorphism on Coronary Outcome of Kawasaki Disease in Southern Chinese Population"],"prefix":"10.3389","volume":"12","author":[{"given":"Linyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanyan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanran","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40674-016-0053-58","article-title":"TNF and IL-1 targeted treatment in kawasaki disease.","volume":"2","author":"Aeschlimann","year":"2016","journal-title":"Curr. Treatment Opt. Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword.","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNFreceptor and its ligandenhance T-cell growthand dendritic-cell function.","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8638096","DOI":"10.1155\/2018\/8638096","article-title":"ABCC4 variants modify susceptibility to kawasaki disease in a southern chinese population.","volume":"2018","author":"Che","year":"","journal-title":"Dis. Markers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cyto.2018.08.029","article-title":"TBXA2R rs4523 G allele is associated with decreased susceptibility to Kawasaki disease.","volume":"111","author":"Che","year":"","journal-title":"Cytokine"},{"key":"B6","first-page":"147","article-title":"Association between levels of tnf-\u03b1 and tnf-\u03b1 promoter \u2013308 a\/a polymorphism in children with kawasaki disease.","volume":"102","author":"Chien","year":"2003","journal-title":"J. Formos. Med. Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e004878","DOI":"10.1161\/JAHA.116.004878","article-title":"Bone marrow-derived MicroRNA-223 works as an endocrine genetic signal in vascular endothelial cells and participates in vascular injury from Kawasaki disease.","volume":"6","author":"Chu","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"I2","DOI":"10.1136\/ard.58.2008.i2","article-title":"Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.","volume":"58","author":"Darnay","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"B9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-5793(91)80803-B","article-title":"Tumor necrosis factor characterization at the molecular, cellular and in vivo level.","volume":"289","author":"Fiers","year":"1991","journal-title":"FEBS Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4730507","DOI":"10.1155\/2019\/4730507","article-title":"The IL-1B gene polymorphisms rs16944 and rs1143627 contribute to an increased risk of coronary artery lesions in southern chinese children with Kawasaki disease.","volume":"2019","author":"Fu","year":"2019","journal-title":"J. Immunol. Res."},{"key":"B11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(05)81361-7","article-title":"Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease.","volume":"124","author":"Furukawa","year":"1994","journal-title":"J. Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"590480","DOI":"10.3389\/fneur.2020.590480","article-title":"RANK\/RANKL\/OPG signaling in the brain: a systematic review of the literature.","volume":"11","author":"Glasnovic","year":"2020","journal-title":"Front. Neurol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1011039216251","article-title":"Cytokine modulation with immune g-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.","volume":"21","author":"Gupta","year":"2001","journal-title":"J. Clin. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.oraloncology.2007.06.003","article-title":"Association of TNF-alpha and TNFR1 promoters and 3\u2019 UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians.","volume":"44","author":"Gupta","year":"2008","journal-title":"Oral Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/biom11020329","article-title":"Structure-Based virtual screening of tumor necrosis factor-alpha inhibitors by cheminformatics approaches and bio-molecular simulation.","volume":"11","author":"Halim","year":"2021","journal-title":"Biomolecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1006\/excr.1999.4733","article-title":"Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling.","volume":"254","author":"Inoue","year":"2000","journal-title":"Exp. Cell Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cyto.2019.03.001","article-title":"Cytokine profile of macrophage activation syndrome associated with Kawasaki disease.","volume":"119","author":"Jinkawa","year":"2019","journal-title":"Cytokine"},{"key":"B18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0022-3476(75)80220-4","article-title":"Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.","volume":"1975","author":"Kato","year":"1975","journal-title":"J. Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12016-020-08783-8789","article-title":"Immunogenetics of Kawasaki disease.","volume":"59","author":"Kumrah","year":"2020","journal-title":"Clin. Rev. Allergy. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/art.38976","article-title":"Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.","volume":"67","author":"Kuo","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokinethat regulates osteoclast differentiationand activation.","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/rheumatology\/keaa299","article-title":"Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.","volume":"60","author":"Mizuta","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and kawasaki disease, council on cardiovascular disease in the young, american heart association.","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s10165-013-0865-864","article-title":"The role of TNF-\u03b1 in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide.","volume":"24","author":"Oharaseki","year":"2013","journal-title":"Modern Rheumatol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s004310051300","article-title":"Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease.","volume":"159","author":"Ohno","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11010-015-2352-z","article-title":"The association between RANKL and Osteoprotegerin gene polymorphisms with breast cancer.","volume":"403","author":"Omar","year":"2015","journal-title":"Mol. Cell Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ng.2007.59","article-title":"ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.","volume":"40","author":"Onouchi","year":"2008","journal-title":"Nat. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.joen.2018.10.022","article-title":"Genetic polymorphisms in RANK and RANKL are associated with persistent apical periodontitis.","volume":"45","author":"Petean","year":"2019","journal-title":"J. Endod."},{"key":"B30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7326\/0003-4819-151-8-200910200-00006","article-title":"Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture.","volume":"151","author":"Richards","year":"2009","journal-title":"Ann. Int. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1136\/archdischild-2014-307536","article-title":"The epidemiology of Kawasaki disease: a global update.","volume":"100","author":"Singh","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"B41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2217\/17460816.3.1.69","article-title":"Pathogenesis of Kawasaki disease: the central role of TNF-\u03b1.","volume":"3","author":"Stringer","year":"2008","journal-title":"Fut. Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/INF.0000000000000271","article-title":"Five years of Kawasaki disease in the Netherlands: a national surveillance study.","volume":"33","author":"Tacke","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1586\/eri.12.101","article-title":"Management of acute and refractory Kawasaki disease.","volume":"10","author":"Tacke","year":"2012","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.humimm.2011.02.004","article-title":"A regulatory polymorphism in promoter region of TNFR1 gene is associated with Kawasaki disease in Chinese individuals.","volume":"72","author":"Wang","year":"2011","journal-title":"Hum. Immunol."},{"key":"B35","first-page":"808","article-title":"Infliximab as a novel therapy for refractory Kawasaki disease.","volume":"31","author":"Weiss","year":"2004","journal-title":"J. Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3760\/cma.j.issn.0254-6450.2019.10.022","article-title":"[Association between TNFRSF11A and TNFRSF11B gene polymorphisms and the outcome of hepatitis C virus infection].","volume":"40","author":"Wu","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"B37","doi-asserted-by":"publisher","first-page":"CD012448","DOI":"10.1002\/14651858.CD012448","article-title":"TNF-alpha blockers for the treatment of Kawasaki disease in children.","volume":"8","author":"Yamaji","year":"2019","journal-title":"Cochrane Database. Syst. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1038\/sj.cdd.4401403","article-title":"Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte\/macrophage lineage precursor cells.","volume":"11","author":"Yang","year":"2004","journal-title":"Cell Death Differ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"BSR20182356","DOI":"10.1042\/bsr20182356","article-title":"The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis.","volume":"39","author":"Yang","year":"2019","journal-title":"Biosci. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"576152","DOI":"10.3389\/fimmu.2020.576152","article-title":"Clinical Significance of serum soluble TNF receptor I\/II ratio for the differential diagnosis of tumor necrosis factor receptor-associated periodic syndrome from other autoinflammatory diseases.","volume":"11","author":"Yasumura","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.691282\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T10:22:14Z","timestamp":1629195734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.691282\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":41,"alternative-id":["10.3389\/fgene.2021.691282"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.691282","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"article-number":"691282"}}